CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pilulka Lekarny as is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pilulka Lekarny as
Ceskomoravska 2408/1a, Praha 9 - Liben
Phone: +420 222703000p:+420 222703000 PRAHA, 190 00  Czech Republic Ticker: PINKPINK
Business Summary
Pilulka Lekarny as is a Czech Republic-based company, which is a chain of drug stores operator. The network of pharmacies under the Pilulka Lekarny brand was established at the beginning of 2015 and is part of pharmaceutical group in the Czech Republic and Slovakia.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
5912 Drug stores and proprietary stores
5999 Miscellaneous retail stores, not elsewhere classified

General Information
Number of Employees: 350 (As of 12/31/2023)
Outstanding Shares: 2,706,678 (As of 12/31/2023)
Stock Exchange: PRG


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024